Skip to content 
Insights into the future of the pharmaceutical industry: global trends and emerging challenges
With the advancement of science and technology, changes in population structure and the evolution of medical policies, the global pharmaceutical […]
Fluoxetine API Market: Generic Drug Opportunities After Patent Expiry
Fluoxetine, a selective serotonin reuptake inhibitor (SSRI), is one of the most widely prescribed antidepressants globally. Originally launched under the
Fluoxetine API Market: Generic Drug Opportunities After Patent Expiry Read More »
Post-Valsartan Impurity Crisis: New Quality Control Standards for Cardiovascular APIs
The pharmaceutical industry was shaken in 2018 by the global recall of valsartan, a commonly used antihypertensive drug, due to
Post-Valsartan Impurity Crisis: New Quality Control Standards for Cardiovascular APIs Read More »
Metformin API for Diabetes: Evolving Formulations and Rising Quality Demands
Metformin hydrochloride is one of the most prescribed oral hypoglycemic agents worldwide, serving as the first-line treatment for type 2
Metformin API for Diabetes: Evolving Formulations and Rising Quality Demands Read More »
Polymorphism in Gabapentin: Implications for API Quality and Formulation Performance
Gabapentin is a widely prescribed antiepileptic and neuropathic pain medication. As with many pharmaceutical active ingredients, polymorphism—the ability of a
Polymorphism in Gabapentin: Implications for API Quality and Formulation Performance Read More »
Paclitaxel as an Anticancer API: The Battle Between Natural Extraction and Semi-Synthetic Technology
Paclitaxel, a powerful chemotherapy drug widely used in the treatment of various cancers such as ovarian, breast, and lung cancer,
